← All companies

Sanofi S.A. (SNY)

Hold Current rating · 2 reports

2026-07-31

Hold Recap: Q2 2026

Beat, Raise, Sell-Off: Sanofi Cuts Three Programmes and Concedes the 2031 Base Case
2026-04-24

Hold Recap: Q1 2026

A 13.6% Top Line That Converts to 2.2% Operating Income: Currency, the Regeneron Split, and the 2031 Clock Take Sanofi's Quarter Back